News
A completed Request for private sector organization screening (PSOS) form is required in specific instances to sponsor eligible organizations for a security clearance with the Contract Security ...
However, despite its ambitions and efforts to compete with established players, Faraday Future's stock performance has been volatile. Investors are curious about the future of FFIE stock ...
Transnet SOC Ltd (Transnet) today issued a Request for Qualification to commence the selection process for a partner in the establishment of a rolling stock leasing company (LeaseCo). LeaseCo will ...
Former House Speaker Nancy Pelosi’s stock portfolio has taken a major hit in 2025, aligning with the broader market sell-off. To recap, Pelosi continued with her Congress trades in Q1 2025, adding ...
A ticker in the Toronto Stock Exchange shows North American stock markets closed low, again, after a roller-coaster day. (Evan Mitsui/CBC) Barry Schwartz, chief investment officer at Baskin Wealth ...
The shares closed the day at $188.40, down 7.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the ...
It takes on average four months for the stock market to recover from a correction, defined as a 10% to 19.9% decline from a recent peak, according to investment research and analytics firm CFRA ...
Intel and TSMC have tentatively agreed to form a joint venture that would run ... while Intel did not immediately respond to a request for comment. Intel’s foundry division produces chips ...
FormFactor is expected to suffer from sluggishness in the semiconductor demand that is likely to hurt the top line as well as contracting gross margin, making the stock risky for investors.
(Reuters) -Intel and Taiwan Semiconductor Manufacturing Co have recently discussed a preliminary agreement to form a joint venture ... respond to a Reuters request for comment.
Shares of Sarepta Therapeutics (NASDAQ:SRPT) fell in the premarket on Thursday following news regarding a clinical hold requested by the EU drug regulator, European Medicines Agency (EMA), on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results